(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
Sisram Medical Ltd, an investment holding company, designs, develops, manufactures, and sells energy-based aesthetic medical, minimally invasive treatment systems, and non-energy based devices and cosmeceuticals in the Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa...
Stats | |
---|---|
Dagens volum | 1.49M |
Gjennomsnittsvolum | 613 464 |
Markedsverdi | 1.66B |
EPS | HKD0 ( 2024-03-21 ) |
Neste inntjeningsdato | ( HKD0 ) 2024-06-27 |
Last Dividend | HKD0.173 ( 2023-08-24 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 6.68 |
ATR14 | HKD0.0220 (0.62%) |
Volum Korrelasjon
Sisram Medical Ltd Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Sisram Medical Ltd Korrelasjon - Valuta/Råvare
Sisram Medical Ltd Økonomi
Annual | 2023 |
Omsetning: | HKD359.29M |
Bruttogevinst: | HKD219.53M (61.10 %) |
EPS: | HKD0.0673 |
FY | 2023 |
Omsetning: | HKD359.29M |
Bruttogevinst: | HKD219.53M (61.10 %) |
EPS: | HKD0.0673 |
FY | 2022 |
Omsetning: | HKD354.48M |
Bruttogevinst: | HKD202.23M (57.05 %) |
EPS: | HKD0.0862 |
FY | 2021 |
Omsetning: | HKD294.29M |
Bruttogevinst: | HKD166.86M (56.70 %) |
EPS: | HKD0.0710 |
Financial Reports:
No articles found.
Sisram Medical Ltd Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0.157 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.173 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.100 | 2019-06-21 |
Last Dividend | HKD0.173 | 2023-08-24 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 5 | -- |
Total Paid Out | HKD0.610 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.83 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.83 | |
Div. Directional Score | 7.59 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
3833.HK | Ex Dividend Junior | 2023-06-02 | Sporadic | 0 | 0.00% | |
1713.HK | Ex Dividend Junior | 2023-06-21 | Annually | 0 | 0.00% | |
0746.HK | Ex Dividend Knight | 2023-08-11 | Semi-Annually | 0 | 0.00% | |
2314.HK | Ex Dividend Junior | 2023-08-11 | Semi-Annually | 0 | 0.00% | |
1283.HK | Ex Dividend Junior | 2023-09-22 | Semi-Annually | 0 | 0.00% | |
0341.HK | Ex Dividend Junior | 2023-09-12 | Annually | 0 | 0.00% | |
6083.HK | Ex Dividend Knight | 2023-06-12 | Semi-Annually | 0 | 0.00% | |
1843.HK | Ex Dividend Knight | 2023-09-05 | Annually | 0 | 0.00% | |
0868.HK | Ex Dividend Knight | 2023-08-11 | Semi-Annually | 0 | 0.00% | |
0016.HK | Ex Dividend Knight | 2023-11-06 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0877 | 1.500 | 8.25 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0513 | 1.200 | 8.29 | 9.95 | [0 - 0.3] |
returnOnEquityTTM | 0.0706 | 1.500 | -0.327 | -0.490 | [0.1 - 1] |
payoutRatioTTM | 0.333 | -1.000 | 6.67 | -6.67 | [0 - 1] |
currentRatioTTM | 2.92 | 0.800 | 0.419 | 0.335 | [1 - 3] |
quickRatioTTM | 1.746 | 0.800 | 4.44 | 3.55 | [0.8 - 2.5] |
cashRatioTTM | 0.800 | 1.500 | 6.67 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0651 | -1.500 | 8.91 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.0940 | 2.00 | 9.97 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.0756 | 2.00 | 9.96 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0884 | -1.500 | 9.65 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.611 | 1.000 | 3.15 | 3.15 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.106 | 1.000 | 9.88 | 9.88 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 1.099 | 1.000 | 5.00 | 5.00 | [0.2 - 2] |
assetTurnoverTTM | 0.586 | 0.800 | 9.43 | 7.54 | [0.5 - 2] |
Total Score | 10.35 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 6.71 | 1.000 | 9.42 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0706 | 2.50 | -0.210 | -0.490 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.0756 | 2.00 | 9.97 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 38.26 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.0940 | 2.00 | 9.97 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.333 | 1.500 | 6.67 | -6.67 | [0 - 1] |
pegRatioTTM | -1.470 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.122 | 1.000 | 9.44 | 0 | [0.1 - 0.5] |
Total Score | 4.83 |
Sisram Medical Ltd
Sisram Medical Ltd, an investment holding company, designs, develops, manufactures, and sells energy-based aesthetic medical, minimally invasive treatment systems, and non-energy based devices and cosmeceuticals in the Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa. It offers products and treatments portfolio, including hair removal, skin rejuvenation, acne and acne scars, body and face contouring, pigmentation and skin resurfacing, fat grafting, dermal facial fillers, skin tissue remodelling injectables, personal care, aesthetic dentistry, trans epidermal delivery, cellulite treatment, stretch marks, vascular and pigmented lesions, hydradermabrasion, blepharoplasty-non surgical eyelid lift, liposuction, feminine health, and sexual rehabilitation. The company manufactures, distributes, and sells medical equipment. It offers its products under the Alma, Soprano, Harmony, Copulla, Foshion, Accent, and LMNT brands. Sisram Medical Ltd was incorporated in 2013 and is headquartered in Caesarea, Israel.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.